A_Good_Day_2 Saturday, 08/12/17 08:37:23 PM Re: Reyeton post# 115256 0 Post # of 142257 How about this scenario: The patent is rejected 3/28/17 AVXL receives great results from BIIB's MTA. Talks with BIIB bear fruit and a plan is hatched. AVXL requests re-consideration of the patent with expanded use in MS in combination with BIIB's drug. Patent is approved around Sept 1st. AVXL/BIIB partnership is announced Sept 11th.